The risk of misclassification during diagnosis of malnutrition in retroperitoneal sarcoma patients

2021 ◽  
Vol 46 ◽  
pp. S707
Author(s):  
A. Casirati ◽  
G. Vandoni ◽  
S. Della Valle ◽  
G. Greco ◽  
C. Morosi ◽  
...  
Author(s):  
Fabio Tirotta ◽  
Alessandro Parente ◽  
Thomas Richardson ◽  
Ahmed Almonib ◽  
Caroline Evenden ◽  
...  

2020 ◽  
Vol 152 ◽  
pp. S649
Author(s):  
M. Nuñez Baez ◽  
A. Montero ◽  
X. Chen-Zhao ◽  
A. Acosta ◽  
B. Alvarez ◽  
...  

2020 ◽  
Vol 13 (8) ◽  
pp. e235549
Author(s):  
Skand Shekhar ◽  
Julie Chen ◽  
Kaniksha Desai

A middle-aged woman with end-stage renal disease (ESRD) due to obstructive nephropathy presented to the hospital for an episode of unresponsiveness and hypoglycaemia. Initially, she was diagnosed with hypoglycaemia associated with ESRD and was discharged. However, she returned to the hospital after experiencing tonic–clonic seizures and recurrent hypoglycaemia. Her hypoglycaemia workup revealed an elevated insulin-like growth factor 2 (IGF2) to IGF1 ratio consistent with paraneoplastic IGF2 secretion. Subsequently, a CT abdomen revealed a retroperitoneal mass, found to be a retroperitoneal sarcoma. Her hypoglycaemia was treated with glucocorticoids and growth hormone. Surgical debulking of her tumour was attempted, but she expired due to postoperative haemorrhagic shock. Doege-Potter syndrome is a rare cause of hypoglycaemia which should be suspected in any new-onset, worsening, inexplicable or refractory hypoglycaemia, particularly in non-diabetic ESRD. Here we present a report of retroperitoneal sarcoma presenting with hypoglycaemia in a patient with ESRD without diabetes.


Cancer ◽  
2006 ◽  
Vol 106 (7) ◽  
pp. 1610-1616 ◽  
Author(s):  
Geoffrey A. Porter ◽  
Nancy N. Baxter ◽  
Peter W. T. Pisters

2017 ◽  
Vol 117 (1) ◽  
pp. 87-92 ◽  
Author(s):  
Anastasia Constantinidou ◽  
Robin L. Jones

2016 ◽  
Vol 25 (4) ◽  
pp. 697-711 ◽  
Author(s):  
Rebecca A. Gladdy ◽  
Abha Gupta ◽  
Charles N. Catton

Author(s):  
Malcolm H. Squires ◽  
Cecilia G. Ethun ◽  
Erin E. Donahue ◽  
Jennifer H. Benbow ◽  
Colin J. Anderson ◽  
...  

2018 ◽  
Vol 100 (2) ◽  
pp. 516-527 ◽  
Author(s):  
Falk Roeder ◽  
Ingo Alldinger ◽  
Matthias Uhl ◽  
Ladan Saleh-Ebrahimi ◽  
Simon Schimmack ◽  
...  

2017 ◽  
Author(s):  
Armen Parsyan ◽  
Abha Gupta ◽  
Charles Catton ◽  
Rebecca Gladdy

Retroperitoneal sarcomas (RPSs) are a heterogeneous group of mesenchymal tumors. The mainstay of treatment of RPS is curative surgical resection, which often involves a multivisceral resection. The predominant pattern of failure in RPS is local recurrence, which poses significant management challenges and limits survival. There is a paucity of high-level evidence to guide the management of primary and recurrent RPS, mainly due to the rarity of the disease. This review highlights the challenges and decision making in the diagnosis and management of recurrent RPS.  This review contains 6 figures, 5 tables and 50 references Key words: chemotherapy, distant recurrence, leiomyosarcoma, liposarcoma, local recurrence, radiation therapy, retroperitoneal sarcoma, surgical resection 


Sign in / Sign up

Export Citation Format

Share Document